Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing

NCT06406114 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT06406114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06406114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Recruiting
Start date
May 5, 2025
Completion date
December 31, 2028
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic allergy, beta lactam adverse reaction, cephalosporin allergy, cephalosporin reaction, drug allergy, drug hypersensitivity, drug-induced anaphylaxis